scholarly journals Corrigendum to circRNA_0084043 promote malignant melanoma progression via miR-153-3p/Snail axis

Author(s):  
Wenkang Luan ◽  
Yan Shi ◽  
Zhou Zhou ◽  
Yun Xia ◽  
Jinlong Wang
2018 ◽  
Vol 156 ◽  
pp. 52-59 ◽  
Author(s):  
Elisabetta Panza ◽  
Giuseppe Ercolano ◽  
Paola De Cicco ◽  
Chiara Armogida ◽  
Giosuè Scognamiglio ◽  
...  

Cancers ◽  
2020 ◽  
Vol 12 (8) ◽  
pp. 2328 ◽  
Author(s):  
Corinna Kosnopfel ◽  
Tobias Sinnberg ◽  
Birgit Sauer ◽  
Heike Niessner ◽  
Alina Muenchow ◽  
...  

Secreted factors play an important role in intercellular communication. Therefore, they are not only indispensable for the regulation of various physiological processes but can also decisively advance the development and progression of tumours. In the context of inflammatory disease, Y-box binding protein 1 (YB-1) is actively secreted and the extracellular protein promotes cell proliferation and migration. In malignant melanoma, intracellular YB-1 expression increases during melanoma progression and represents an unfavourable prognostic marker. Here, we show active secretion of YB-1 from melanoma cells as opposed to benign cells of the skin. Intriguingly, YB-1 secretion correlates with the stage of melanoma progression and depends on a calcium- and ATP-dependent non-classical secretory pathway leading to the occurrence of YB-1 in the extracellular space as a free protein. Along with an elevated YB-1 secretion of melanoma cells in the metastatic growth phase, extracellular YB-1 exerts a stimulating effect on melanoma cell migration, invasion, and tumourigenicity. Collectively, these data suggest that secreted YB-1 plays a functional role in melanoma cell biology, stimulating metastasis, and may serve as a novel biomarker in malignant melanoma that reflects tumour aggressiveness.


2014 ◽  
Vol 27 (4) ◽  
pp. 630-639 ◽  
Author(s):  
Yorihisa Kotobuki ◽  
Lingli Yang ◽  
Satoshi Serada ◽  
Atsushi Tanemura ◽  
Fei Yang ◽  
...  

Oncotarget ◽  
2017 ◽  
Vol 8 (49) ◽  
pp. 85401-85414 ◽  
Author(s):  
Wenkang Luan ◽  
Rubo Li ◽  
Liang Liu ◽  
Xin Ni ◽  
Yan Shi ◽  
...  

2020 ◽  
Vol 22 ◽  
pp. e00182 ◽  
Author(s):  
Ivana Špaková ◽  
Miroslava Rabajdová ◽  
Katarína Dubayová ◽  
Vladimíra Nagyová ◽  
Martina Bago Pilátová ◽  
...  

2011 ◽  
Vol 39 (1) ◽  
pp. 374-377 ◽  
Author(s):  
Paweł Link-Lenczowski ◽  
Anna Lityńska

Although melanoma is one of the most studied malignancies, it still remains challenging for biomedicine. Since aberrant glycosylation has been considered as an important hallmark of cancer for many years, melanoma glycomic studies give a chance of better understanding the biology of the disease. The multistage nature of melanoma development, which is accompanied by changes in the expression of adhesion receptors from the integrin family, provides a chance for searching for neoglycoforms of proteins that can be considered as future sensitive melanoma biomarkers. The β1,6-branching, sialylation and fucosylation seem to be important modifications of integrin N-glycans in the case of malignant melanoma progression.


2019 ◽  
Vol 493 ◽  
pp. S149
Author(s):  
I. Špaková ◽  
M. Rabajdová ◽  
P. Urban ◽  
M. Mareková

Sign in / Sign up

Export Citation Format

Share Document